Literature DB >> 1410588

Pharmacokinetics of nicotinamide and its effect on blood pressure, pulse and body temperature in normal human volunteers.

M R Stratford1, A Rojas, D W Hall, M F Dennis, S Dische, M C Joiner, R J Hodgkiss.   

Abstract

The pharmacokinetics of nicotinamide were studied in four human volunteers after oral doses of 1-6 g. Plasma concentrations and clearance rates of the vitamin were found to be dose-dependent, with a half-life of approximately 7-9 h for the two highest doses administered (4 and 6 g), approximately 4 h with 2 g and approximately 1.5 h with a 1-g dose. Peak concentrations ranged from 0.7 to 1.1 mumol.ml-1 after a 6-g dose. The time to reach peak plasma concentration was dose independent with a broad range from 0.73 to 3 h. In this study, nicotinamide had no detectable effect on blood pressure, pulse or body temperature.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1410588     DOI: 10.1016/0167-8140(92)90193-x

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  12 in total

1.  Death of a truck driver: fatal nicotinamide poisoning associated with intravenous drug use.

Authors:  K B Nolte; R B Palmer; N G Rao
Journal:  West J Med       Date:  1999-04

Review 2.  Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide.

Authors:  M Saunders; S Dische
Journal:  Br J Cancer Suppl       Date:  1996-07

3.  Nicotinamide and pentoxifylline increase human leucocyte filterability: a possible mechanism for reduction of acute hypoxia.

Authors:  D J Honess; Y Kitamoto; M R Rampling; N M Bleehen
Journal:  Br J Cancer Suppl       Date:  1996-07

4.  C/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice.

Authors:  Pierre Kyme; Nils H Thoennissen; Ching Wen Tseng; Gabriela B Thoennissen; Andrea J Wolf; Kenichi Shimada; Utz O Krug; Kunik Lee; Carsten Müller-Tidow; Wolfgang E Berdel; W David Hardy; Adrian F Gombart; H Phillip Koeffler; George Y Liu
Journal:  J Clin Invest       Date:  2012-08-27       Impact factor: 14.808

5.  Pharmacokinetics and biochemistry studies on nicotinamide in the mouse.

Authors:  M R Stratford; M F Dennis
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

6.  Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations.

Authors:  A Rojas; R J Hodgkiss; M R Stratford; M F Dennis; H Johns
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

7.  Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.

Authors:  D J Chaplin; M R Horsman; D W Siemann
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

8.  Nicotinamide pharmacokinetics in humans: effect of gastric acid inhibition, comparison of rectal vs oral administration and the use of saliva for drug monitoring.

Authors:  M R Stratford; M F Dennis; P Hoskin; H Phillips; R J Hodgkiss; A Rojas
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

Review 9.  NAD+ metabolism as a target for metabolic health: have we found the silver bullet?

Authors:  Niels J Connell; Riekelt H Houtkooper; Patrick Schrauwen
Journal:  Diabetologia       Date:  2019-02-16       Impact factor: 10.122

10.  Carbogen breathing with nicotinamide improves the oxygen status of tumours in patients.

Authors:  V M Laurence; R Ward; I F Dennis; N M Bleehen
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.